Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma (Articolo in rivista)

Type

• Articolo in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma (Articolo in rivista) (literal)

Anno

• 1988-01-01T00:00:00+01:00 (literal)

Alternative label

• Bellia V, Ferrara G, Cibella F, Cuttitta G, Visconti A, Insalaco G, Mirto M, Peralta G (1988)
  Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma
  in Postgraduate medical journal
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Bellia V, Ferrara G, Cibella F, Cuttitta G, Visconti A, Insalaco G, Mirto M, Peralta G (literal)

Pagina inizio

• 583 (literal)

Pagina fine

• 586 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 64 (literal)

Rivista

• Postgraduate medical journal (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali

• 4 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

• 754 (literal)

Note

• PubMe (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• Clinica Pneumologica dell'Università, Palermo Consiglio Nazionale delle Ricerche, Istituto di Fisiopatologia Respiratoria, Palermo (literal)

Titolo

• Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma (literal)

Abstract

• The effects of a new inhaled antimuscarinic drug, oxitropium bromide, and of a slow-release theophylline preparation upon nocturnal asthma were compared in a placebo-controlled double-blind study. Two samples were studied: 12 patients received oxitropium at 600 micrograms (6 subjects) or at 400 micrograms t.i.d. (6 subjects) whereas 11 received theophylline at 300 mg b.i.d. Morning dipping, assessed by the fall in peak flow overnight, was significantly reduced in the periods when either active drug was taken, whereas no difference was noticed during the placebo administration. No significant difference was noticed between results obtained with either active drug, as well as with either dosage of oxitropium. No subject reported side effects of oxitropium, as compared to three subjects reporting nausea, vomiting and tremors after theophylline. Oxitropium proves to be a valuable alternative to theophylline in nocturnal asthma, since it is equally potent, safer and does not require the titration of dosage (literal)

Prodotto di

• Tecnologie Innovative per lo Studio dei Disturbi Respiratori nel Sonno (ME.P01.014.009) (Modulo)
• Istituto di biomedicina e di immunologia molecolare \"Alberto Monroy\" (IBIM) (Istituto)
• Epidemiologia delle broncopneumopatie e di altre malattie croniche non comunicabili (ME.P01.014.001) (Modulo)

Autore CNR

• GIUSEPPINA CUTTITTA (Persona)
• FABIO CIBELLA (Persona)
• GIUSEPPE INSALACO (Unità di personale interno)

Incoming links:

Prodotto

• Istituto di biomedicina e di immunologia molecolare \"Alberto Monroy\" (IBIM) (Istituto)
• Tecnologie Innovative per lo Studio dei Disturbi Respiratori nel Sonno (ME.P01.014.009) (Modulo)
• Epidemiologia delle broncopneumopatie e di altre malattie croniche non comunicabili (ME.P01.014.001) (Modulo)

Autore CNR di

• GIUSEPPINA CUTTITTA (Persona)
• GIUSEPPE INSALACO (Unità di personale interno)
• FABIO CIBELLA (Persona)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Postgraduate medical journal (Rivista)